Navigation Links
Arno Therapeutics, Inc. Appoints Randy Thurman to the Board of Directors
Date:1/31/2013

FLEMINGTON, N.J., Jan. 31, 2013 /PRNewswire/ -- Arno Therapeutics, Inc. (OTCBB: ARNI), a clinical-stage biopharmaceutical company focused on the development of oncology therapeutics, today announced the appointment of Mr. Randy Thurman to its Board of Directors. With over 30 years of health care industry experience, Mr. Thurman brings a wealth of operational, financial, and business development expertise to Arno.  

"We are extremely pleased to welcome Mr. Thurman to our Board of Directors," said Glenn Mattes , CEO of Arno. "With his extensive knowledge, broad industry network, and history of strong leadership, we are confident that Mr. Thurman will provide Arno with invaluable guidance as we continue the development of our company and its exciting clinical stage assets."

Mr. Thurman became an Operating Partner for AEA Investors LP in October 2012 and previously held the same role with New Mountain Capital LLC since 2008. Mr. Thurman is also Executive Chairman of CogentHMG and was previously Founder, Chairman & CEO of VIASYS Healthcare, Inc., a global leader in respiratory, neurological and medical/surgical technologies. VIASYS Healthcare Inc. was acquired in a transaction which represented a four-fold increase in enterprise value over the five years the company was public. VIASYS was named by Smart Money magazine as one of the "10 Best Investments of the Decade," and Mr. Thurman was named an Ernst & Young Entrepreneur of the Year in 2007. Prior to joining VIASYS Healthcare Inc., Mr. Thurman was CEO of Strategic Reserves, LLC, which provided strategic leadership and M&A advisory services to bio-pharmaceutical, genomic and medical device companies. As Chairman of the Board of Enzon Inc., Mr. Thurman guided the company's growth from a $70 million market capitalization to over $2.5 billion. Previously, he was Chairman & CEO of Corning
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
2. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
3. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
4. Caliber and ImmunGene Launch Valor Biotherapeutics, a Joint Venture to Develop Antibody-Interferon Fusion Therapeutics to Treat Cancers
5. Cell Therapeutics, Inc. (CTI) Reduces Net Loss for Third Quarter and Nine Months Ended September 30, 2012 Compared to Same Periods in 2011
6. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
7. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
8. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
9. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
10. Regulus Appoints Mark G. Foletta to its Board of Directors
11. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)...  Express Scripts Holding Company (Nasdaq: ESRX ) ... Scripts stockholders of $600.1 million, or $0.88 per diluted ... Table 4, were $1.44 for the second quarter. ... across healthcare are validating the need for size and ... "But, what matters most is how that size and ...
(Date:7/28/2015)... July 28, 2015  Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment ... the SENZA-RCT results in the Online First edition ... American Society of Anesthesiologists. The ... was the first to directly compare spinal cord ...
(Date:7/28/2015)... The Physician-Patient Alliance for Health & Safety ... Surviving Your Hospital Stay ." "Help us ... of these patients went home from hospital," said ... referring to the patient stories presented at ... Promote Continuous Monitoring of Patients on Opioids (shown ...
Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... PharmaNet Development Group, Inc. and Anapharm Europe, ... to the pharmaceutical, biotechnology, generic drug and medical ... the collaborative provision of bioanalytical services officially ended ... with the termination of this relationship, Dr. Maria ...
... Corporation (Nasdaq: SIAL ) will hold its ... Wednesday, February 9, 2011 at 10:00 AM Central Time ... , 10:00 AM CT (11:00 AM ET)Toll Free: ... parties may listen via live audio broadcast and view ...
Cached Medicine Technology:PharmaNet and Anapharm Europe Formally End Joint Venture 2
(Date:7/28/2015)... ... July 28, 2015 , ... ... Heart Center at Memorial Regional Hospital, providing expert, streamlined total advanced heart care ... suited to provide extensive heart services under one roof, including the treatment of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the ... Canales and Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons ... Canales are proud to be bestowed such a prestigious title. , The Press ...
(Date:7/28/2015)... MA (PRWEB) , ... July 28, 2015 , ... ... look, user-friendly navigation, portal to access industry practices, consumer education, resource library, floor ... has visitors from around the globe and offers regular posts with valuable links ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... patented products, announces Shelled Out, a new household invention that makes shelling eggs ... $253.4 billion by 2020,” says Scott Cooper, CEO and Creative Director of World ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... patented products, announces the Lost and Found, a breakthrough technological invention. It ... , "Revenue for the consumer electronic industry reached a record high of $211.3 ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5
... Officials from the EU's 27 member states decided that milk and ... the same way as any other novel food. ... Working Group, after Europe was last week hauled into the cloned ... cow had been born on a UK farm. ...
... February issue of the American Naturalist is the first ... eat their offspring when they have been cuckolded during ... decision a father can make is to cannibalize his ... Fraser University), Lawrence Dill (Simon Fraser University), and Jeffrey ...
... have shown that a drug commonly used to lower ... with Marfan syndrome and also prevents muscle degeneration in ... are reported online this week at Nature Medicine. ... Dietz, M.D., discovered that treating Marfan mice with losartan ...
... issue of CANCER, a peer-reviewed journal of the American Cancer ... drug may negatively affect treatment efficacy. At 3.5 years, the ... ceased tamoxifen treatment. ,In the clinical practice ... stop tamoxifen within one year, a rate twice as high ...
... athletes with ventricular arrhythmias also possess dysfunctional right ventricles.//, ... come up with a relatively rare but dangerous condition ... beats at an abnormal rate and rhythm. Further, a ... with VA also have worthless right ventricles., ,The ...
... in Head Start programs have discovered that those from ... at higher risk for being overweight. ,The ... found that Mexican children “were almost twice as likely ... of ethnic groups, including non-Mexican Hispanic children.” ...
Cached Medicine News:Health News:EU States Agree on Clone Food Plan 2Health News:Common BP Drug Treats Muscular Dystrophy 2Health News:Common BP Drug Treats Muscular Dystrophy 3Health News:Tamoxifen Discontinuation Rates Surprisingly High 2Health News:Probing the Effect of Endurance Exercise on Athletes' Hearts 2Health News:Probing the Effect of Endurance Exercise on Athletes' Hearts 3Health News:Probing the Effect of Endurance Exercise on Athletes' Hearts 4Health News:Head Start Kids in ESL Families More Prone to Obesity 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: